Clinical Trials Facilitation and Coordination Group
E553856
The Clinical Trials Facilitation and Coordination Group is a working group under the Heads of Medicines Agencies that focuses on harmonizing and streamlining clinical trial assessment and regulation across European countries.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Clinical Trials Facilitation and Coordination Group canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T5873095 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Clinical Trials Facilitation and Coordination Group Context triple: [HMA, hasWorkingGroup, Clinical Trials Facilitation and Coordination Group]
-
A.
Center for Clinical Standards and Quality
The Center for Clinical Standards and Quality is a division of the U.S. federal health system responsible for developing, implementing, and enforcing national healthcare quality and safety standards across Medicare- and Medicaid-participating providers.
-
B.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
-
C.
Centre for Collaboration with Registry Networks
The Centre for Collaboration with Registry Networks is a specialized unit within Norway’s public health system that coordinates and advances the use of health registries for research, surveillance, and policy development.
-
D.
NCI-Designated Cancer Centers Program
The NCI-Designated Cancer Centers Program is a U.S. network of leading academic and research institutions recognized for excellence in cancer research, treatment, and prevention.
-
E.
Patient-Centered Outcomes Research Institute
The Patient-Centered Outcomes Research Institute is an independent, nonprofit organization in the United States that funds and promotes comparative clinical effectiveness research to help patients and clinicians make better-informed healthcare decisions.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Clinical Trials Facilitation and Coordination Group Target entity description: The Clinical Trials Facilitation and Coordination Group is a working group under the Heads of Medicines Agencies that focuses on harmonizing and streamlining clinical trial assessment and regulation across European countries.
-
A.
Center for Clinical Standards and Quality
The Center for Clinical Standards and Quality is a division of the U.S. federal health system responsible for developing, implementing, and enforcing national healthcare quality and safety standards across Medicare- and Medicaid-participating providers.
-
B.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
-
C.
Centre for Collaboration with Registry Networks
The Centre for Collaboration with Registry Networks is a specialized unit within Norway’s public health system that coordinates and advances the use of health registries for research, surveillance, and policy development.
-
D.
NCI-Designated Cancer Centers Program
The NCI-Designated Cancer Centers Program is a U.S. network of leading academic and research institutions recognized for excellence in cancer research, treatment, and prevention.
-
E.
Patient-Centered Outcomes Research Institute
The Patient-Centered Outcomes Research Institute is an independent, nonprofit organization in the United States that funds and promotes comparative clinical effectiveness research to help patients and clinicians make better-informed healthcare decisions.
- F. None of above. chosen
Statements (38)
| Predicate | Object |
|---|---|
| instanceOf |
regulatory coordination body
ⓘ
working group ⓘ |
| abbreviation | CTFG ⓘ |
| activity |
development of common positions on clinical trial regulatory issues
ⓘ
drafting of guidance documents on clinical trials for regulators and stakeholders ⓘ exchange of experience between national authorities on clinical trial assessment ⓘ support to harmonized implementation of EU Clinical Trials Directive and Regulation ⓘ |
| collaboratesWith |
European Medicines Agency
ⓘ
national competent authorities for medicines in EU and EEA Member States ⓘ |
| country | European countries ⓘ |
| field |
clinical trials regulation
ⓘ
medicines regulation ⓘ |
| focus |
clinical trial authorization procedures
ⓘ
good clinical practice implementation ⓘ implementation of EU clinical trials legislation ⓘ regulatory guidance for sponsors and investigators ⓘ |
| goal |
enhance patient safety in clinical research through coordinated regulation
ⓘ
improve efficiency of clinical trial assessment in Europe ⓘ reduce regulatory divergence between European countries for clinical trials ⓘ |
| hasMember | representatives of national medicines agencies in EU and EEA ⓘ |
| jurisdiction |
European Economic Area Member States
ⓘ
linked to:
European Economic Area
European Union Member States ⓘ
linked to:
Member States of the European Union
|
| language | English ⓘ |
| parentOrganization | Heads of Medicines Agencies Clinical Trials Working Group structure ⓘ |
| partOf | Heads of Medicines Agencies ⓘ |
| purpose |
coordination between national competent authorities on clinical trials
ⓘ
facilitation of multinational clinical trials in Europe ⓘ harmonization of clinical trial assessment in Europe ⓘ streamlining clinical trial regulation across European countries ⓘ |
| regionServed | Europe ⓘ |
| sector |
pharmaceutical regulation
ⓘ
public health ⓘ |
| supervises | harmonized approaches to clinical trial assessment among member authorities ⓘ |
| topic |
assessment of clinical trial safety and efficacy data
ⓘ
ethics and regulatory interface in clinical trials ⓘ multinational clinical trial applications ⓘ risk-based approaches to clinical trial oversight ⓘ |
| website | https://www.hma.eu/ctfg.html ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Clinical Trials Facilitation and Coordination Group Description of subject: The Clinical Trials Facilitation and Coordination Group is a working group under the Heads of Medicines Agencies that focuses on harmonizing and streamlining clinical trial assessment and regulation across European countries.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.